Invest now
Procter & Gamble Health share price
Balanced risk
You have to be logged in to add this to Watchlist.- ₹5,954.00(0.53%)August 14, 2026 15:28:35 PM IST
- NSE
- BSE
- Vol : 20.56 K (NSE + BSE)Last 20 day avg : 18.95 K
Procter & Gamble Health is trading 0.53% upper at Rs 5,954.00 as compared to its last closing price. Procter & Gamble Health has been trading in the price range of 5,974.55 & 5,907.00. Procter & Gamble Health has given 4.82% in this year & -2.38% in the last 5 days. Procter & Gamble Health has TTM P/E ratio 32.30 as compared to the sector P/E of 33.00.There are 1 analysts who have initiated coverage on Procter & Gamble Health. There are 0.00 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 96.15 Crores in its last quarter.Listed peers of Procter & Gamble Health include Sun Pharmaceutical Industries (-0.92%), Divi's Laboratories (-%), Torrent Pharmaceuticals (-0.74%).The Mutual Fund holding in Procter & Gamble Health was at 9.05% in 30 Jun 2026. The MF holding has increased from the last quarter. The FII holding in Procter & Gamble Health was at 6.33% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 15 Aug 2026, 12:06 AM IST
- BetaLow volatility0.30Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.02The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry2.62Annual dividends as a percentage of the stock price.
- P/BIn line with historical values18.74The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/ELower than historical values30.38Price-to-earnings ratio based on trailing 12-month earnings
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Procter & Gamble Health Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,924.90 | -0.92 | 4,61,837.11 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 8,500.00 | - | 2,25,648.29 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,840.30 | -0.74 | 1,84,102.87 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,450.00 | -0.75 | 1,17,138.71 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,140.00 | -2.81 | 1,13,715.44 | 21.19 | 4.24 | 0.09 | 14.22 |
Mutual Fund Ownership
View allProcter & Gamble Health Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-06 | Quarterly Results & Interim Dividend |
| 2025-11-05 | Quarterly Results & Interim Dividend |
| 2025-05-29 | Audited Results & Final Dividend |
About the company Procter & Gamble Health
- IndustryBiotechnology & Drugs
- ISININE199A01012
- BSE Code500126
- NSE CodePGHL
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Procter & Gamble Health Share Price FAQs
Procter & Gamble Health is trading at 5954.00 as on Fri Aug 14 2026 09:58:35. This is 0.53% upper as compared to its previous closing price of 5922.40.
The market capitalization of Procter & Gamble Health is 9896.48 Cr as on Fri Aug 14 2026 09:58:35.
The average broker rating on Procter & Gamble Health is Buy. The breakup of analyst rating is given below -
- 0.00 analysts have given a strong buy rating
- 1 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 0.00 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Procter & Gamble Health is 6955.00 whereas the 52 wk low is 4699.70
Procter & Gamble Health can be analyzed on the following key metrics -
- TTM P/E: 32.30
- Sector P/E: 33.00
- Dividend Yield: 2.62%
- D/E ratio: -
Procter & Gamble Health reported a net profit of 326.91 Cr in 2026.
The Mutual Fund Shareholding was 9.05% at the end of 30 Jun 2026.
Quick Links
EQUITY QUICK LINKS
Procter & Gamble Health QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.